AU2002211217A1 - Method of treating stroke - Google Patents

Method of treating stroke

Info

Publication number
AU2002211217A1
AU2002211217A1 AU2002211217A AU1121702A AU2002211217A1 AU 2002211217 A1 AU2002211217 A1 AU 2002211217A1 AU 2002211217 A AU2002211217 A AU 2002211217A AU 1121702 A AU1121702 A AU 1121702A AU 2002211217 A1 AU2002211217 A1 AU 2002211217A1
Authority
AU
Australia
Prior art keywords
treating stroke
patient
stroke
treating
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211217A
Other languages
English (en)
Inventor
James Allen Clemens
David Lodge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2002211217A1 publication Critical patent/AU2002211217A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Processing Of Stones Or Stones Resemblance Materials (AREA)
AU2002211217A 2000-10-13 2001-09-28 Method of treating stroke Abandoned AU2002211217A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24042200P 2000-10-13 2000-10-13
US60240422 2000-10-13
PCT/US2001/027738 WO2002032389A1 (en) 2000-10-13 2001-09-28 Method of treating stroke

Publications (1)

Publication Number Publication Date
AU2002211217A1 true AU2002211217A1 (en) 2002-04-29

Family

ID=22906451

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211217A Abandoned AU2002211217A1 (en) 2000-10-13 2001-09-28 Method of treating stroke

Country Status (8)

Country Link
EP (1) EP1330233B1 (es)
JP (1) JP2004511507A (es)
AT (1) ATE288254T1 (es)
AU (1) AU2002211217A1 (es)
CA (1) CA2420994A1 (es)
DE (1) DE60108775T8 (es)
ES (1) ES2236321T3 (es)
WO (1) WO2002032389A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050088175A (ko) 2002-12-17 2005-09-02 메드이뮨 백신즈 인코포레이티드 생물활성 물질의 고압 분무 건조
KR20060094421A (ko) * 2005-02-24 2006-08-29 고재영 신규한 뇌졸중 치료제 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20000944A1 (es) * 1998-07-31 2000-09-20 Lilly Co Eli Derivados de sulfonamida

Also Published As

Publication number Publication date
DE60108775T2 (de) 2006-01-12
DE60108775T8 (de) 2006-08-24
EP1330233A1 (en) 2003-07-30
JP2004511507A (ja) 2004-04-15
WO2002032389A1 (en) 2002-04-25
DE60108775D1 (de) 2005-03-10
CA2420994A1 (en) 2002-04-25
ATE288254T1 (de) 2005-02-15
ES2236321T3 (es) 2005-07-16
EP1330233B1 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
HK1069339A1 (en) Substituted diketopiperazines as oxytocin antagonists
HK1091481A1 (en) Therapeutic agents useful for treating pain
EG25822A (en) Quinolinyl-pyrrolopyrazoles
IL143388A0 (en) Compositions and methods for stimulating gastrointestinal motility
WO2004029031A3 (en) Therapeutic piperazine compounds
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
AUPR177300A0 (en) Therapeutic methods
MXPA05013587A (es) Agentes terapeuticos utiles para el tratamiento del dolor.
WO2005056524A3 (en) Therapeutic agents useful for treating pain
WO2002096362A3 (en) Method for treating fibrotic diseases or other indications vi
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
SE0004101D0 (sv) New use
WO2007047893A3 (en) Use of dasatinib for the treatment of bone metastasis
GEP20043231B (en) Resorcinol Composition
AU2002211217A1 (en) Method of treating stroke
SE0004827D0 (sv) Therapeutic compounds
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
MY133957A (en) "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor"
AU2002213232A1 (en) Treatment of demyelinating diseases by administering gpe
AU2002213240A1 (en) Treatment of demyelinating diseases by administering gpe